This compound is an active pharmaceutical ingredient reference standard, structurally characterized as a quinoline derivative with a dihydroxyheptenoic acid side chain and a cyclopropyl group. It is provided for analytical and quality control applications in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1159631-31-8
(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid
pharmaceutical raw material
15S-HETE
pharmaceutical raw material
2,6-dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid
pharmaceutical raw material
Cinacalcet Related Compound C
pharmaceutical raw material
N-(3,5-Dimethyltricyclo[3.3.1.1~3,7~]decan-1-yl)-4-O-alpha-L-erythro-hexopyranosyl-beta-D-threo-hexopyranosylamine
pharmaceutical raw material
All-trans-retinal
pharmaceutical raw material
Pevonedistat hydrochloride
pharmaceutical raw material
Insulin aspart
pharmaceutical raw material
(Z,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
VGYFMXBACGZSIL-DBBWNDPISA-N
C1CC1C2=NC3=CC=CC=C3C(=C2/C=C\[C@H](C[C@H](CC(=O)O)O)O)C4=CC=C(C=C4)F